On December 14, 2020, the China National
Intellectual Property Administration (short for the CNIPA) issued a
notice that listed out the latest amendments of Guidelines for Patent
Examination, and informed such amendments will be implemented
on January 15, 2021. For understanding such amendments
conveniently, this article intends to summarize and introduce the
contents concerning the aspects, for example, supplementing
experimental dada, novelty of compounds, inventive step of
compounds, depositary institution of biological material,
definition of monoclonal antibody, inventive step of inventions
relating to the field of biology, and the like.
In this amendment, all of the amended
contents focus on examination of invention applications in the
field of chemistry. For clarification, the contents
underlined in black are the expressions after
amended, and the contents with strikeout in red
are the expressions before amended hereinafter.
